Navigation Links
Many Rheumatoid Arthritis Patients May Skip Meds: Study
Date:9/3/2014

WEDNESDAY, Sept. 3, 2014 (HealthDay News) -- Many patients with severe rheumatoid arthritis don't take their expensive medications as prescribed, a new British study finds.

Failure to take the drugs correctly reduces their effectiveness and may lead to a worsening of symptoms, warned researchers from the University of Manchester.

Rheumatoid arthritis develops when your immune system begins to attack itself, and symptoms include inflammation, pain and swelling in the joints and internal organs.

The study included 286 patients who had rheumatoid arthritis for seven years and had been prescribed anti-TNF drugs, which cost about $13,000 to $20,000 a year per patient. Anti-TNF drugs include etanercept (Enbrel), adalimumab (Humira) and golimumab (Simponi).

Twenty-seven percent of the patients said they didn't take the medications as directed at least once over the first six months after being prescribed the drugs, according to the study published recently in the journal Rheumatology.

It's not clear whether the patients' failure to take the drugs as prescribed was deliberate or accidental, and further research is needed to learn more about why this occurs, the researchers said.

"If patients do not take their medication as prescribed it is likely to have a significant effect on whether they respond to therapy and could mean that their condition deteriorates more quickly, affecting their quality of life," study author and rheumatology expert Dr. Kimme Hyrich said in a university news release. "Non-adherence is also a waste of scarce health care resources and something that needs to be addressed."

Anti-TNF drugs have transformed the lives of many patients with rheumatoid arthritis and related disorders, Alan Silman, medical director of Arthritis Research UK, said in the news release.

"This success has been at a considerable cost to the [National Health Service] but there was always the assumption that patients prescribed these drugs will have the necessary regular injections," Silman said.

"The fact that a considerable proportion of patients are missing doses of these very expensive agents is worrying, as clearly their effectiveness would be reduced," he added.

More information

The U.S. National Library of Medicine has more about rheumatoid arthritis.

SOURCE: University of Manchester, news release, Aug. 28, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
2. Genotyping can predict disease outcomes in rheumatoid arthritis patients
3. Benaroya Research Institute scientists identify drivers of rheumatoid arthritis
4. Molecules involved in rheumatoid arthritis angiogenesis identified
5. Scientists awarded grant to develop diagnostics for cancer, rheumatoid arthritis, colitis
6. Same-day double knee replacement safe for select rheumatoid arthritis patients
7. A New Article Releases 17 Homeopathic Remedies for Rheumatoid Arthritis – Vinamy
8. Bel Marra Health Reports on Recent Research Revealing a Link Between Intestinal Bacteria and Rheumatoid Arthritis
9. Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both
10. Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
11. Rheumatoid arthritis and heart disease: Mayo Clinic studies shed light on dangerous connection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Rheumatoid Arthritis Patients May Skip Meds: Study 
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 to ... are given out in five categories. They are:, ,     Patient Marketing, ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Research and Markets has announced the addition of the "Menopause Drugs ... ... Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks ... What are the key drugs marketed for ... Menopause market? What are the unit prices and annual ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus Therapeutics ... discovery and development of innovative medicines targeting microRNAs, today ... 2016 financial results on Thursday, March 2, 2017 after ... conference call and webcast on March 2, 2017 at ... full year 2016 financial results and provide a general ...
(Date:2/23/2017)... -- The fast-growing cannabis market is expected to ... . According to the 2017 Legal Marijuana Outlook, published by ... 283,422 jobs by 2020, with an implied growth rate of ... The accelerating pace of cannabis legalization is considered as the ... which will further create more business ventures and boost the ...
Breaking Medicine Technology: